DOP13: Plasma metabolite fingerprint could discriminate inflammatory bowel disease patients from healthy subjectsECCO’23 CopenhagenYear: 2023
Authors: Farkas, K.(1)*;Endre, G.(2);Bacsur, P.(1);Resál, T.(1);Kocsmárszky-Koósz, V.(2);Tömösi, F.(2);Tóth, E.(2);Rutka, M.(1);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Goretity, Á.(2);Thibodeau, I.(2);Molnár, T.(1);
(1)Szent-Györgyi Albert Medical School- University of Szeged, Department of Medicine, Szeged, Hungary;(2)MP Health Ltd., MP Health Ltd., Budapest, Hungary;
DOP14: Identification and validation of a lipidomic signature as a novel diagnostic biomarker of paediatric Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Salihovic, S.(1);Nyström, N.(2)*;Bache-Wiig Mathisen, C.(3);Andersen, S.(4);Olbjørn, C.(5);Perminow, G.(6);Opheim, R.(7);Detlie, T.E.(8);Huppertz-Hauss, G.(9);Bazov, I.(1);Kruse, R.(10);Lindqvist, C.M.(1);Hedin, C.R.H.(11);Carlson, M.(12);Öhman, L.(13);Magnusson, M.(13);Keita, Å.V.(14);Söderholm, J.D.(14);D'Amato, M.(15);Orešič, M.(1);Repsilber, D.(1);Hyötyläinen, T.(16);Hoivik, M.L.(3);Halfvarson, J.(17);
(1)School of Medical Sciences- Faculty of Medicine and Health, Örebro University, Örebro, Sweden;(2)Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden;(3)Department of Gastroenterology- Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway;(4)Department of Pediatrics, Vestfold Hospital trust, Tønsberg, Norway;(5)Department of Pediatrics and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway;(6)Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway;(7)Department of Gastroenterology- Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway;(8)Department of Gastroenterology- Akershus University Hospital and Institute of Clinical Medicine, University of Oslo, Lørenskog, Norway;(9)Department of Gastroenterology, Telemark Hospital Trust, Skien, Norway;(10)Department of Clinical Research Laboratory- Faculty of Medicine and Health, Örebro University, Örebro, Sweden;(11)Department of Medicine Solna and Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden;(12)Department of Medical Sciences, Uppsala University, Uppsala, Sweden;(13)Department of Microbiology and Immunology and Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;(14)Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden;(15)Clinical Epidemiology Division- Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;(16)School of Science and Technology, Örebro University, Örebro, Sweden;(17)Department of Gastroenterology- Faculty of Medicine and Health, Örebro University, Örebro, Sweden;
DOP15: Intestinal ultrasound correlates with colonoscopy and biomarkers, and can be used in a tight monitoring approach to assess response to therapy in Crohn's disease: a multicentre prospective studyECCO’23 CopenhagenYear: 2023
Authors: Morão, B.(1)*;Revés, J.(1);Nascimento, C.(1);Frias Gomes, C.(1);Cúrdia Gonçalves, T.(2);Freitas, M.(2);Castro, F.(2);Moreira, M.J.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Macedo, C.(5);Ferreira, M.(5);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
(1)Hospital Beatriz Ângelo, Gastroenterology, Lisbon, Portugal;(2)Hospital da Senhora da Oliveira - Life and Health Sciences Research Institute - School of Medicine - University of Minho - Braga - ICVS/3B's - PT Government Associate Laboratory, Gastroenterology, Guimarães/Braga, Portugal;(3)Unidade Local de Saúde de Castelo Branco- EPE- Hospital Amato Lusitano, Gastroenterology, Castelo Branco, Portugal;(4)Centro Hospitalar de São João, Gastroenterology, Porto, Portugal;(5)Centro Hospitalar Universitário de Coimbra, Gastroenterology, Coimbra, Portugal;
DOP16: Anti-integrin ⍺vβ6 autoantibodies predate Ulcerative Colitis diagnosis by up to 10 years and are associated with adverse disease-related outcomesECCO’23 CopenhagenYear: 2023
Authors: Livanos, A.(1)*;Dunn, A.(2);Fischer, J.(2);Ungaro, R.C.(1);Turpin, W.(3);Lee, S.H.(3);Rui, S.(1);Del Valle, D.M.(2);Jougon, J.J.(4);Martinez-Delgado, G.(2);Riddle, M.S.(5);Murray, J.A.(6);Laird, R.M.(7);Torres, J.(8);Agrawal, M.(1);Magee, J.S.(9);Dervieux, T.(10);Gnjatic, S.(2);Sheppard, D.(11);Sands, B.E.(1);Porter, C.K.(7);Croitoru, K.(3);Petralia, F.(12);Colombel, J.F.(1);Mehandru, S.(1);
(1)Icahn School of Medicine at Mount Sinai, Henry D. Janowitz Division of Gastroenterology, New York, United States;(2)Icahn School of Medicine at Mount Sinai, Precision Immunology Institute, New York, United States;(3)Mount Sinai Hospital, Zane Cohen Centre for Digestive Diseases, Toronto- Ontario, Canada;(4)Claude Huriez Hospital- University of Lille, Hepato-Gastroenterology Department, Lille, France;(5)University of Nevada- Reno School of Medicine, Office of Medical Research, Reno, United States;(6)Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, United States;(7)Naval Medical Research Center, Enteric Diseases Department, Silver Spring, United States;(8)Hospital Beatriz Ângelo, Gastroenterology Division, Loures, Portugal;(9)Walter Reed National Military Medical Center, Gastroenterology, Bethesda, United States;(10)Prometheus Laboratories, Chief Scientific Officer, San Diego, United States;(11)University of California San Francisco, Division of Pulmonary- Critical Care- Allergy and Sleep- Department of Medicine, San Francisco, United States;(12)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, United States;CCC-GEM Project Research Consortium and OSCCAR Consortium
DOP17: HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry.ECCO’23 CopenhagenYear: 2023
Authors: Calafat Sard, M.(1,2)*;Súria, C.(3);Mesonero, F.(4);de Francisco, R.(5);Yagüe Caballero, C.(6);de la Peña, L.(7);Hernández-Camba, A.(8);Marcè, A.(9);Gallego, B.(10);Martín-Vicente, N.(11);Rivero, M.(12); Iborra, M.(13);Guerra, I.(14); Carrillo-Palau, M.(15);Madero, L.(16);Burgueño, B.(17); Montfort, D.(18);Torres, G.(19);Teller, M.(20);Ferrer Rosique, J.Á.(21);Vega Villaamil, P.(22);Roig, C.(23);Ponferrada, Á.(24); Betoré Glaría, E.(25);Zabana, Y.(2,26); P. Gisbert, J.(2,27);Alcaide, N.(28);Camps, B.(29);Legido, J.(30);González Vivo, M.(31);Bosca-Watts, M.M.(32);Pérez-Martínez, I.(5);Casas Deza, D.(6,33);Guardiola, J.(7);Arranz Hernández, L.(8); Navarro, M.(34);Gomollon, F.(2,10);Cañete, F.(1,2); Mañosa, M.(1,2);Domènech, E.(1,2);
(1)Hospital Universitari Germans Trias i Pujol, Gastroenterology department, Badalona, Spain;(2)CIBERehd, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas, Madrid, Spain;(3)Hospital Clínic Universitari de València- Universitat de València, Gastroenterology Department, Valencia, Spain;(4)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(5)Hospital Universitario Central de Asturias- Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Gastroenterology Department, Oviedo, Spain;(6)Hospital Universitario Miguel Servet, Gastroenterology Department, Zaragoza, Spain;(7)Hospital Universitari de Bellvitge, Gastroenterology Department, L'hospitalet de Llobregat, Spain;(8)Hospital Universitario Nuestra Señora de Candelaria, Gastroenterology Department, Santa Cruz de Tenerife, Spain;(9)Hospital de Sant Joan Despí Moisès Broggi, Gastroenterology Department, Sant Joan Despí, Spain;(10)Hospital Clínico Universitario «Lozano Blesa»- Instituto de Investigación Sanitaria- IIS Aragón, Gastroenterology Department, Zaragoza, Spain;(11)Hospital Universitario de Galdakao, Gastroenterology Department, Galdakao, Spain;(12)Hospital Universitario Marqués de Valdecilla- Instituto de Investigación Marqués de Valdecilla IDIVAL, Gastroenterology Department, Santander, Spain;(13)Hospital Universitari i Politècnic la Fe de València, Gastroenterology Department, Valencia, Spain;(14)Hospital Universitario de Fuenlabrada e IdiPAZ, Gastroenterology Department, Fuenlabrada, Spain;(15)Hospital Universitario de Canarias, Gastroenterology Department, La Laguna, Spain;(16)Hospital General Universitario Dr Balmis de Alicante. ISABIAL, Gastroenterology Department, Alicante, Spain;(17)Hospital Rio Hortega, Gastroenterology Department, Valladolid, Spain;(18)Consorci Sanitari de Terrassa, Gastroenterology Department, Terrassa, Spain;(19)Hospital Universitari Arnau de Vilanova de Lleida, Gastroenterology Department, Lleida, Spain;(20)Althaia- Xarxa Assistencial Universitària de Manresa, Gastroenterology Department, Manresa, Spain;(21)Hospital Universitario Fundación Alcorcón, Gastroenterology Department, Alcorcón, Spain;(22)Complexo Hospitalario Universitario de Ourense, Gastroenterology Department, Ourense, Spain;(23)Hospital Universitari de la Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(24)Hospital Universitario Infanta Leonor, Gastroenterology Department, Madrid, Spain;(25)Hospital Universitario San Jorge, Gastroenterology Department, Huesca, Spain;(26)Hospital Universitari Mútua de Terrassa, Gastroenterology Department, Terrassa, Spain;(27)Hospital Universitario de la Princesa- IIS-Princesa- UAM- Madrid, Gastroenterology Department, Madrid, Spain;(28)Hospital Clínico de Valladolid, Gastroenterology Department, Valladolid, Spain;(29)Hospital de Granollers, Gastroenterology Department, Granollers, Spain;(30)Complejo Asistencial de Segovia, Gastroenterology Department, Segovia, Spain;(31)Hospital Parc de Salut Mar, Gastroenterology Department, Barcelona, Spain;(32)Hospital Clínic Universitari de València- Universitat de València, Gastroenterology Department, València, Spain;(33)Instituto de Investigación Sanitaria de Aragón IISA., Gastroenterology, Zaragoza, Spain;(34)Hospitalde Sant Joan Despí Moisès Broggi, Gastroenterology Department, Sant Joan Despí, Spain;on behalf of GETECCU.
DOP18: Brain structural correlates of fatigue in active and quiescent Crohn's DiseaseECCO’23 CopenhagenYear: 2023
Authors: Thomann, A.(1)*;Schmitgen, M.(2);Szabo, K.(3);Ebert, M.(4);Reindl, W.(4);Wolf, C.(5);
(1)University Medical Center Mannheim- Medical Faculty Mannheim- Heidelberg University- Mannheim- Germany, Department of Medicine II, Mannheim, Germany;(2)Heidelberg University Hospital, Dept. of General Psychiatry, Heidelberg, Germany;(3)University Medical Centre Mannheim- Heidelberg University, Dept. of Neurology, Mannheim, Germany;(4)University Medical Centre Mannheim- Heidelberg University, Dept. of Medicine II, Mannheim, Germany;(5)Heidelberg University Hospital, Department of General Psychiatry, Heidelberg, Germany;
DOP19: Incidence and initial disease presentation of inflammatory bowel diseases in Denmark: findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)ECCO’23 CopenhagenYear: 2023
Authors: Attauabi, M.(1,2)*;Madsen, G.R.(2,3);Wewer, A.V.(2,4);Bendtsen, F.(2,3);Jakobsen, C.(2,4);Dorn-Rasmussen, M.(2,4);Malham, M.(2,4);Theede, K.(2,3);Bjerrum, J.T.(1);Boysen, T.(2,3);Seidelin, J.B.(1);Burisch, J.(2,3);
(1)Copenhagen University Hospital - Herlev and Gentofte, Department of Gastroenterology and Hepatology, Herlev, Denmark;(2)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents- and Adults, Hvidovre, Denmark;(3)Copenhagen University Hospital - Amager and Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(4)Copenhagen University Hospital - Amager and Hvidovre, Department of Pediatrics and Adolescent Medicine, Hvidovre, Denmark;
DOP20: The impact of early life antibiotics on the occurrence of paediatric inflammatory bowel disease - a nationwide study from 1995 – 2018ECCO’23 CopenhagenYear: 2023
Authors: Jawad, A.(1);Jansson, S.(1,2);Malham, M.(1,2)*;Wewer, V.(1,2);
(1)Copenhagen University Hospital - Hvidovre, Department of Paediatric and Adolescence Medicine, Hvidovre, Denmark;(2)Copenhagen University Hospital - Hvidovre, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adult
DOP21: Disease activity patterns of paediatric Inflammatory Bowel Disease – A Danish nationwide cohort study 1996-2018ECCO’23 CopenhagenYear: 2023
Authors: Wewer, M.D.(1,2,3)*;Jansson, S.(3,4,5);Malham, M.(3,4,6);Burisch, J.(1,3);Wewer, V.(3,4,7);
(1)Hvidovre Hospital, Gastrounit- Medical Division, Hvidovre, Denmark;(2)University of Copenhagen, Medical Faculty, Copenhagen, Denmark;(3)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;(4)Hvidovre Hospital, The Department of Paediatrics and Adolescent Medicine, Hvidovre, Denmark;(5)University of Aarhus, Medical Faculty, Aarhus, Denmark;(6)University of Copenhagen, Section of Epidemiology- Department of Public Health, Copenhagen, Denmark;(7)University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark;
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort StudyECCO’23 CopenhagenYear: 2023
Authors: Faye, A.(1)*;Allin, K.(2);Iversen, A.(3);Agrawal, M.(4);Faith, J.(5);Colombel, J.F.(5);Jess, T.(2);
(1)NYU Grossman School of Medicine, Medicine, New York City, United States;(2)PREDICT- Aalborg University, Medicine, Copenhagen, Denmark;(3)PREDICT, Medicine, Copenhagen, Denmark;(4)Icahn School of Medicine at Mount Sinai- PREDICT, Medicine, New York City, United States;(5)Icahn School of Medicine at Mount Sinai, Medicine, New York City, United States;
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST surveyECCO’23 CopenhagenYear: 2023
Authors: Roukas, C.(1)*;Miller , L.(2);Hamborg, T.(2);Gordeev, V.(1);Lindsay, J.(3);Norton, C.(4);Mihaylova, B.(1);
(1)Wolfson Institute of Population Health, Health Economics and Policy Research Unit, London, United Kingdom;(2)Wolfson Institute of Population Health, Pragmatic Clinical Trials Unit, London, United Kingdom;(3)Blizard Institute, Centre for Immunobiology, London, United Kingdom;(4)Faculty of Nursing, Midwifery and Palliative Care, London, United Kingdom;
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, CanadaECCO’23 CopenhagenYear: 2023
Authors: Fantodji, C.(1)*;Rousseau, M.C.(1);Nicolau, B.(2);Madathil, S.(2);Benedetti, A.(3);Jantchou, P.(4);
(1)Institut national de la recherche scientifique INRS- Université du Québec, Epidemiology and Biostatistics Unit- Centre Armand-Frappier Santé Biotechnologie, Laval, Canada;(2)McGill University, Faculty of Dental Medicine and Oral Health Sciences, Montréal, Canada;(3)McGill University, Departments of Medicine and of Epidemiology- Biostatistics & Occupational Health, Montréal, Canada;(4)Sainte-Justine University Hospital Centre CHU Sainte-Justine, Department of Gastroenterology- Hepatology- and Nutrition, Montréal, Canada;
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United StatesECCO’23 CopenhagenYear: 2023
Authors: Brenner, E.(1)*;Zhang, X.(2);Long, M.(3);Dubinsky, M.(4);Kappelman, M.(2);
(1)University of North Carolina, Pediatrics, Chapel Hill, United States;(2)University of North Carolina at Chapel Hill, Pediatrics, Chapel Hill, United States;(3)University of North Carolina at Chapel Hill, Medicine, Chapel Hill, United States;(4)Mount Sinai, Pediatrics, New York, United States;
DOP26: Burden of perianal disease and perianal surgery in Crohn's disease over different therapeutic eras – a population-based study from western Hungary between 1977–2020, data from the Veszprem county cohortECCO’23 CopenhagenYear: 2023
Authors: Gonczi, L.(1);Lakatos, L.(2);Golovics, P.A.(3);Pandur, T.(4);David, G.(2);Erdelyi, Z.(2);Szita, I.(2);LakatosPhD, P.L.(5)*;
(1)Semmelweis University, Department of Medicine and Oncology, Budapest, Hungary;(2)Ferenc Csolnoky Hospital, Department of Gastroenterology, Veszprem, Hungary;(3)Hungarian Defence Forces Medical Centre, Department of Gastroenterology, Budapest, Hungary;(4)Grof Esterhazy Hospital, Department of Gastroenterology, Papa, Hungary;(5)Mcgill University Health Center, IBD Centre, Montréal, Canada;
DOP27: Disease activity patterns in the first 5 years after diagnosis in children with Crohn's disease: a population-based study.ECCO’23 CopenhagenYear: 2023
Authors: Distante, M.(1);Rotulo, S.(1)*;Ranalli, M.(1);Pedace, E.(1);Lionetti, P.(2);Arrigo, S.(3);Alvisi, P.(4);Miele, E.(5);Martinelli, M.(5);Zuin, G.(6);Bramuzzo, M.(7);Cananzi, M.(8);Aloi, M.(1);
(1)Umberto I Hospital- Sapienza University of Rome, Department of Maternal and Child Health- Pediatric Gastroenterology and Liver Unit, Rome, Italy;(2)Meyer Children's Hospital, Unit of Gastroenterology and Nutrition, Florence, Italy;(3)IRCCS- Istituto Giannina Gaslini, Gastroenterologia ed Endoscopia Pediatrica, Genoa, Italy;(4)Maggiore Hospital, Pediatric Gastroenterology Unit, Bologna, Italy;(5)University of Naples “Federico II”, Department of Translational Medical Science- Section of Pediatrics, Naples, Italy;(6)Fondazione MBBM- San Gerardo Hospital, Pediatric Department- University of Milano Bicocca, Monza, Italy;(7)IRCCS “Burlo Garofolo”, Institute for Maternal and Child Health, Trieste, Italy;(8)University Hospital of Padova, Unit of Gastroenterology- Digestive Endoscopy- Hepatology and Care of Children with Liver Transplantation, Padova, Italy;SIGENP IBD Working Group: C. Romano, M.T. Illiceto, S. Salvatore, V. Romagnoli, C. De Giacomo, D.Knafelz, G. Barera, M. Corpino, R. Cozzali, A. Ravelli, G. Castellucci, P. Diaferia, D. Dilillo, M. Baldi, E. Felici, C. Banzato, P.M. Pavanello
DOP28: Aconitate decarboxylase 1 (ACOD1) represents a crucial regulator of monocyte recruitment, survival and proinflammatory status in intestinal inflammationECCO’23 CopenhagenYear: 2023
Authors: Jones, G.R.(1)*;Hegarty, L.(1);T'Jonck, W.(1);Adams, C.(1);Drury, B.(1);Byrne, A.(2);Ho, G.T.(1);Bain, C.(1);
(1)The Queens Medical Research Institute, Centre for inflammation research, Edinburgh, United Kingdom;(2)Faculty of Medicine- National Heart & Lung Institute, Imperial College, London, United Kingdom;
DOP29: Single cell analysis of Crohn's disease fistula; comparison of different locationsECCO’23 CopenhagenYear: 2023
Authors: Beckerdrs., M.(1)*;Koelink, P.(1);Bemelman, W.(2);Buskens, C.(2);Wildenberg, M.(1);
(1)Tytgat Institute for Liver and Intestinal Research, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC, Surgery, Amsterdam, The Netherlands;
DOP30: Identifying dietary factors and metabolites that may promote healthier Crohn Disease microbiome and mucosal transcriptomics signals as future targets using Diet-OmicsECCO’23 CopenhagenYear: 2023
Authors: Haberman Ziv, Y.(1)*;Braun, T.(1);Amir, A.(1);Levhar, N.(1);Toren, I.(1);Malik, A.(2);Neuman, S.(2);Hadar, R.(1);Efroni, G.(1);Ben-Horin, S.(2);
(1)Sheba Medical Center, Pediatric Gastroenterology, Ramat Gan, Israel;(2)Sheba Medical Center, Gastroenterology, Ramat Gan, Israel;The Leona M. and Harry B. Helmsley Charitable Trust SOURCE consortium investigators
DOP31: Gut metabolomic and compositional signatures predict response to treatment with exclusive enteral nutrition in children with active Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Gerasimidis, K.(1)*;Nichols, B.(1);Briola, A.(1);Havlik, J.(2);Mascellani, A.(2);Milling, S.(3);Ijaz, U.(4);Quince, C.(5);Svolos, V.(1);Russell, R.K.(6);Hansen, R.(7);
(1)University of Glasgow, Human Nutrition, Glasgow, United Kingdom;(2)Czech University of Life Sciences Prague, Food Science, Prague, Czech Republic;(3)University of Glasgow, School of Immunology, Glasgow, United Kingdom;(4)University of Glasgow, School of Engineering, Glasgow, United Kingdom;(5)Earlham Institute, Organisms and Ecosystems, Norwich, United Kingdom;(6)Royal Hospital for Sick Children and Young People, Paediatric Gastroenterology- Hepatology and Nutrition, Edinburgh, United Kingdom;(7)Royal Hospital for Children, Paediatric Gastroenterology- Hepatology & Nutrition, Glasgow, United Kingdom;
DOP32: Crohn's disease stricture matrisome analysis reveals the anti-fibrotic activity of milk-fat globule-epidermal growth factor 8 (MFGE8)ECCO’23 CopenhagenYear: 2023
Authors: Lin, S.(1);Wang, J.(2);Mukherjee, P.(3);Mao, R.(1);West, G.(3);Czarnecki, D.(3);Zhao, S.(3);Elias, M.(3);Nguyen, Q.T.(3);Chandra, J.(3);Le, T.H.N.(3);Chen, M.H.(1);Dejanovic, D.(3);Holubar, S.(4);Olman, M.(3);Southern, B.(3);Hu, S.(5);Gordon, I.O.(5);Atabai, K.(6);Fiocchi, C.(3);Rieder, F.(7)*;
(1)The First Affiliated Hospital of Sun Yat-sen University, Department of Gastroenterology and Hepatology, Guangzhou, China;(2)Xinxiang Medical University, Henan Key Laboratory of Immunology and Targeted Drug, Xinxiang, China;(3)Cleveland Clinic, Inflammation and Immunity, Cleveland, United States;(4)Cleveland Clinic, Colorectal Surgery, Cleveland, United States;(5)Cleveland Clinic, Department of Pathology, Cleveland, United States;(6)University of California San Francisco, Cardiovascular Research Institute, San Francisco, United States;(7)Cleveland Clinic, Gastroenterology- Hepatology and Nutrition, Cleveland, United States;
